Skip to content
OpenCapital
Earnings
Screener
Charts
Portfolio
Pricing
Connect your AI
Get started
Toggle navigation menu
Stocks
BioCryst Pharmaceuticals
Business Segments
Geographic
Revenue percentage
Revenue percentage
BioCryst Pharmaceuticals
·
Geographic
·
1 segment
·
Rolls up to
Concentration Risk %
Breakdown
Segments
Geographic
View metric
Quarterly
Annual
TTM
Segment
Q1 '26
Geographic
90%
Total
—